熱門資訊> 正文

Abivax报告1H结果

2026-09-22 04:09

Abivax press release (ABVX): 1H
The Company had cash, cash equivalents and short-term investments of €402.4 million as of June 30, 2026.

More on Abivax

Abivax: Obefazimod Goes The Distance And So Does My Buy Rating
ABIVAX Société Anonyme (ABVX) Discusses ABTECT Maintenance Part 2 Results and Updated Obefazimod Safety and Efficacy Data in Ulcerative Colitis - Slideshow
Abivax: Latest Obefazimod Data Eases Safety Fears, Brings M&A Back Into Play
Abivax raises $920M as underwriters fully exercise overallotment option
Abivax SA prices upsized $800M ADS offering

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。